Polsinelli Platform Attracts Large Group of Attorneys

Tuesday, June 18, 2013

Citing the firm’s successful business model, commitment to clients and strong leadership, a number of seasoned shareholders and associates recently joined Polsinelli in several of its offices. The attorneys will practice in the firm’s St. Louis and Washington, D.C. offices assisting clients locally and nationally in environmental, toxic tort and commercial litigation, IP, government contracts, and construction related issues. In addition, the firm opened a regional Chattanooga, Tennessee office with four attorneys to serve national clients in corporate, corporate finance, mergers and acquisitions, and real estate matters. These prominent and highly experienced attorneys serve clients in a variety of industries including chemical manufacturing, health care, oil and gas exploration, and real estate.

More >>

Tags:  Polsinelli PC

Weil Advises Morgan Stanley on Bridge Facility for Weyerhaeuser Co.

Tuesday, June 18, 2013

A Weil team advised Morgan Stanley on a senior unsecured 364-day high grade bridge facility in connection with the $2.65 billion acquisition of Longview Timber LLC, a US-based forestry company, by Weyerhaeuser Co., a US real estate trust that is one of the largest producer of wood and cellulose fibers, from Brookfield Asset Management Inc. The bridge facility and the acquisition were announced on June 17, 2013, and the acquisition is expected to close in July.

More >>

Tags:  Weil, Gotshal & Manges, LLP

Paul Hastings Represents Cowen and Company in Smith & Wesson Holding Corporation’s Exchange and Sale of Notes

Tuesday, June 18, 2013

Paul Hastings LLP, a leading global law firm, announced today that the firm represented Cowen and Company, a diversified financial services firm, as placement and exchange agent in connection with the issuance of $75.0 million aggregate principal amount of 5.875% senior notes due 2017 issued by Smith & Wesson Holding Corporation in exchange for approximately $42.8 million of the company’s 9.50% senior notes due 2016 from existing holders of such notes and the purchase by certain of such holders of additional new notes for cash. The firm is also representing Cowen and Company as dealer manager in connection with the company’s cash tender offer for certain of the company’s outstanding common stock.

More >>

Tags:  Paul Hastings, LLP | New York

Davis Polk Advises Santander México on Its Acquisition of ING Group’s Mortgage Business in Mexico

Tuesday, June 18, 2013

Davis Polk is advising Grupo Financiero Santander México, S.A.B. de C.V. in connection with the Ps.643 million acquisition by its subsidiary, Banco Santander (México), S.A., Institución de Banca Múltiple, of ING Hipotecaria, S.A. de C.V., Sociedad Financiera de Objeto Múltiple, Entidad No Regulada, a subsidiary of ING Group. The transaction, which is subject to customary regulatory approvals, is expected to close in the second half of 2013.

More >>

Tags:  Davis Polk & Wardwell LLP | New York

Davis Polk – Thermo Fisher Scientific Inc. $2.46 Billion Common Stock Offering and Forward Sale Agreements

Tuesday, June 18, 2013

Davis Polk advised affiliates of each of J.P. Morgan Securities LLC and Barclays Capital Inc. in connection with the execution of forward sale agreements on approximately 29.6 million shares of Thermo Fisher Scientific Inc.’s common stock (NYSE: TMO) in connection with an SEC-registered offering of an equal number of shares. The approximately 29.6 million shares include approximately 3.9 million shares purchased by the underwriters pursuant to their over-allotment option. In connection with the forward sale agreements, J.P. Morgan Securities LLC and Barclays Capital Inc., each as agent for its respective affiliate, borrowed an aggregate of approximately 29.6 million shares of Thermo Fisher Scientific Inc.’s common stock (approximately 25.7 million shares, in the aggregate, in connection with base forward sale agreements and 3.9 million shares, in the aggregate, in connection with additional forward sale agreements executed in connection with the exercise by the underwriters of their over-allotment option) from third parties and sold these shares to the underwriters. The net proceeds of the offering (assuming physical settlement of the forward sale agreements at the initial forward sale price) are expected to be approximately $2.46 billion.

More >>

Tags:  Davis Polk & Wardwell LLP | New York